acquired
Stage
1
Investors
About
Cybergene AB develops and markets in vitro diagnostic products, specializing in prenatal diagnostics for chromosomal conditions, pregnancy loss analysis, and male infertility testing.
Explore Cybergene's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.